Signaling pathways in systemic lupus erythematosus and therapeutic implications. [PDF]
Balogh L, Kovács VG, Nagy G, Németh T.
europepmc +1 more source
The new Bruton's tyrosine kinase inhibitors SPA8007 and SPA8009 reduce stemness and invasiveness of patient-derived glioblastoma tumorspheres. [PDF]
Jo E +19 more
europepmc +1 more source
Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study. [PDF]
García-Sanz R +15 more
europepmc +1 more source
The diagnostic value of dual-energy CTA for visualising below the knee arteries in peripheral arterial disease: A systematic review. [PDF]
Baars J +8 more
europepmc +1 more source
Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers. [PDF]
Kluitmans DJF +8 more
europepmc +1 more source
The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs. [PDF]
Robak T +4 more
europepmc +1 more source
Exploratory Covalent Docking of Michael-Acceptor Natural Products at Reactive Cysteines in Cancer Tyrosine Kinases. [PDF]
Lobo F +5 more
europepmc +1 more source
Revealing superconducting gap in La<sub>3</sub>Ni<sub>2</sub>O<sub>7-δ</sub> by Andreev reflection spectroscopy under high pressure. [PDF]
Guo J +7 more
europepmc +1 more source
Bing-Neel Syndrome in Waldenström Macroglobulinemia: Updates on Clinical Management and BTK Inhibitor Efficacy. [PDF]
Saburi M, Sekiguchi N.
europepmc +1 more source

